Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 8/2018

Open Access 01-08-2018 | Nephrology - Letter to the editor

The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years

Authors: Jolanta Malyszko, Jacek Zawierucha, Wojciech Marcinkowski, Tomasz Prystacki, Teresa Dryl-Rydzynska, Jacek S. Malyszko, Joanna Matuszkiewicz-Rowinska

Published in: International Urology and Nephrology | Issue 8/2018

Login to get access

Excerpt

Hepatitis B virus (HBV) and hepatitis C (HCV) infections are a global public health problem. …
Literature
1.
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ (2013) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546–1555CrossRef
2.
Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ (2005) National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18:52–61CrossRefPubMed
3.
Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, Jha V, Wang T, Kawaguchi Y, Qian J (2009) Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant 24:1598–1603CrossRefPubMed
4.
5.
6.
Carvalho-Filho RJ, Feldner AC, Silva AE, Ferraz ML (2015) Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol 21:408–422CrossRefPubMedPubMedCentral
7.
8.
Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, Barril G, Scheuermann E, Sonkodi S, Goubau P (2004) HCV Collaborative Group. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 19:904–909CrossRefPubMed
9.
Goodkin DA, Bieber B (2018) International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation. Kidney Int 93:1249CrossRefPubMed
10.
11.
Sperl J, Kreidlova M, Merta D, Chmelova K, Senkerikova R, Frankova S (2018) Paritaprevir/ritonavir/ombitasvir plus dasabuvir regimen in the treatment of genotype 1 chronic hepatitis C infection in patients with severe renal impairment and end-stage renal disease: a real-life cohort. Kidney Blood Press Res 43:594–605CrossRefPubMed
12.
Dejman A, Ladino MA, Roth D (2018) Treatment and management options for the hepatitis C virus infected kidney transplant candidate. Hemodial Int 22(Suppl 1):S36–S44CrossRefPubMed
13.
Jadoul M, Martin P (2017) Hepatitis C treatment in chronic kidney disease patients: the kidney disease improving global outcomes perspective. Blood Purif 43:206–209CrossRefPubMed
Metadata
Title
The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years
Authors
Jolanta Malyszko
Jacek Zawierucha
Wojciech Marcinkowski
Tomasz Prystacki
Teresa Dryl-Rydzynska
Jacek S. Malyszko
Joanna Matuszkiewicz-Rowinska
Publication date
01-08-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-1897-7

Other articles of this Issue 8/2018

International Urology and Nephrology 8/2018 Go to the issue

Nephrology - Original Paper

Variations of the renal function parameters in rectal cancer patients with a defunctioning loop ileostomy

Nephrology - Original Paper

The effect of periodontal disease treatment in patients with continuous ambulatory peritoneal dialysis

Nephrology - Original Paper

Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis

Urology - Original Paper

A novel method for prediction of stone composition: the average and difference of Hounsfield units and their cut-off values

Nephrology - Original Paper

Kidney function and cognitive decline in frail elderly: two faces of the same coin?

Urology - Original Paper

Comparisons of percutaneous versus retroperitoneoscopic cryoablation for renal masses
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits